GIP(Lys37MYR), a novel acylated analogue of glucose-dependent insulinotropic polypeptide (GIP) has enhanced stability, glucose lowering and insulin releasing properties in obese diabetic (ob/ob) mice

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)389-389
JournalIRISH JOURNAL OF MEDICAL SCIENCE
Volume178 (S
Publication statusPublished - 2009

Cite this